Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer Care.

IF 2.8 4区医学 Q2 ONCOLOGY

Current oncology Pub Date : 2024-10-16 DOI:10.3390/curroncol31100461

Jessica L Nickerson, Chloe Cyr, Riley J Arseneau, Stacey N Lee, Stefanie Condon-Oldreive, George Zogopoulos, Keith Roberts, Christina A Kim, Sylvia S W Ng, Masoom Haider, Eva Villalba, Leah Stephenson, Erica Tsang, Brent Johnston, Boris Gala-Lopez, Valerie Cooper, Breffni Hannon, Anne Gangloff, Sharlene Gill, Filomena Servidio-Italiano, Ravi Ramjeesingh

{"title":"Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer Care.","authors":"Jessica L Nickerson, Chloe Cyr, Riley J Arseneau, Stacey N Lee, Stefanie Condon-Oldreive, George Zogopoulos, Keith Roberts, Christina A Kim, Sylvia S W Ng, Masoom Haider, Eva Villalba, Leah Stephenson, Erica Tsang, Brent Johnston, Boris Gala-Lopez, Valerie Cooper, Breffni Hannon, Anne Gangloff, Sharlene Gill, Filomena Servidio-Italiano, Ravi Ramjeesingh","doi":"10.3390/curroncol31100461","DOIUrl":null,"url":null,"abstract":"<p><p>Pancreatic cancer is a complex malignancy associated with poor prognosis and high symptom burden. Optimal patient care relies on the integration of various sectors in the healthcare field as well as innovation through research. The Canadian National Pancreas Conference (NPC) was co-organized and hosted by Craig's Cause Pancreatic Cancer Society and The Royal College of Physicians and Surgeons in November 2023 in Montreal, Canada. The conference sought to bridge the gap between Canadian healthcare providers and researchers who share the common goal of improving the prognosis, quality of life, and survival for patients with pancreatic cancer. The accredited event featured discussion topics including diagnosis and screening, value-based and palliative care, pancreatic enzyme replacement therapy, cancer-reducing treatment, and an overview of the current management landscape. The present article reviews the NPC sessions and discusses the presented content with respect to the current literature.</p>","PeriodicalId":11012,"journal":{"name":"Current oncology","volume":"31 10","pages":"6191-6204"},"PeriodicalIF":2.8000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11506161/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/curroncol31100461","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Pancreatic cancer is a complex malignancy associated with poor prognosis and high symptom burden. Optimal patient care relies on the integration of various sectors in the healthcare field as well as innovation through research. The Canadian National Pancreas Conference (NPC) was co-organized and hosted by Craig's Cause Pancreatic Cancer Society and The Royal College of Physicians and Surgeons in November 2023 in Montreal, Canada. The conference sought to bridge the gap between Canadian healthcare providers and researchers who share the common goal of improving the prognosis, quality of life, and survival for patients with pancreatic cancer. The accredited event featured discussion topics including diagnosis and screening, value-based and palliative care, pancreatic enzyme replacement therapy, cancer-reducing treatment, and an overview of the current management landscape. The present article reviews the NPC sessions and discusses the presented content with respect to the current literature.

查看原文本刊更多论文

2023 年加拿大全国胰腺会议：多学科参与胰腺癌治疗回顾。

胰腺癌是一种复杂的恶性肿瘤，预后差，症状多。最佳的患者护理有赖于医疗保健领域各部门的整合以及研究创新。加拿大全国胰腺会议（NPC）由克雷格事业胰腺癌协会和皇家内外科医学院于 2023 年 11 月在加拿大蒙特利尔共同组织和主办。会议旨在为加拿大医疗服务提供者和研究人员搭建桥梁，他们的共同目标是改善胰腺癌患者的预后、生活质量和生存率。此次会议的讨论主题包括诊断和筛查、以价值为基础的姑息治疗、胰酶替代疗法、减癌治疗以及当前管理状况概述。本文对 NPC 会议进行了回顾，并结合当前文献对会议内容进行了讨论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current oncology ONCOLOGY-

CiteScore

3.30

自引率

7.70%

发文量

664

审稿时长

1 months

期刊介绍： Current Oncology is a peer-reviewed, Canadian-based and internationally respected journal. Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy in Canada to report upon and to review progress in the management of this disease. We encourage submissions from all fields of cancer medicine, including radiation oncology, surgical oncology, medical oncology, pediatric oncology, pathology, and cancer rehabilitation and survivorship. Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.